CrossRefPubMed 46 Gasteiger E, Gattiker A, Hoogland C, Ivanyi I,

CrossRefPubMed 46. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A: ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003, 31:3784–3788.CrossRefPubMed 47. Hulo N, Sigrist CJ, Le Saux V, Langendijk-Genevaux PS, Bordoli L, Gattiker A,

De Castro E, Bucher P, Bairoch A: Recent improvements to the PROSITE database. Nucleic Acids Res 2004, 32:D134-D137.CrossRefPubMed Selleckchem TPCA-1 48. Bendtsen JD, Nielsen H, von Heijne G, Brunak S: Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340:783–795.CrossRefPubMed 49. Dailidiene D, Dailide G, Kersulyte D, Berg DE: Contraselectable streptomycin susceptibility determinant for genetic manipulation and analysis of Helicobacter pylori. Appl Environ Microbiol 2006, 72:5908–5914.CrossRefPubMed 50. Pérez-Pérez GI, Blaser MJ: Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun 1987, 55:1256–1263.PubMed 51. Yao R, Alm RA, Trust TJ, Guerry P: Construction of new Campylobacter cloning BAY 1895344 in vitro vectors and a new mutational cat cassette. Gene 1993, 130:127–130.CrossRefPubMed 52. Woodall CA, Jones MA, Barrow PA, Hinds J, Marsden GL, Kelly DJ, Dorrell N, Wren BW, Maskell DJ:Campylobacter jejuni gene expression in the chick cecum: evidence for adaptation to a low-oxygen environment. Infect Immun 2005, 73:5278–5285.CrossRefPubMed

53. Palyada K, Threadgill D, Stintzi A: Iron acquisition and regulation in Campylobacter jejuni. J Bacteriol 2004, 186:4714–4729.CrossRefPubMed 54. Guerry P, Alm RA, Power ME, Logan SM, Trust TJ: Role of two flagellin genes in Campylobacter motility. J Bacteriol 1991, 173:4757–4764.PubMed 55. Wassenaar TM, Bleumink-Pluym NM, Zeijst BA: Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. Embo J 1991, 10:2055–2061.PubMed 56. Candon HL, Allan BJ, Fraley CD, Gaynor EC: Polyphosphate kinase 1 (PPK1) is a pathogenesis determinant in Campylobacter

jejuni. J Bacteriol 2007, 189:8099–8108.CrossRefPubMed 57. Baqar S, Applebee LA, Bourgeois AL: Erastin concentration Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice. Infect Immun 1995, 63:3731–3735.PubMed 58. Lee LH, Burg E 3rd, Baqar S, Bourgeois AL, Burr DH, Ewing CP, Trust TJ, Guerry P: Evaluation Olopatadine of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni. Infect Immun 1999, 67:5799–5805.PubMed 59. Gun-Munro J, Rennie RP, Thornley JH, Richardson HL, Hodge D, Lynch J: Laboratory and clinical evaluation of isolation media for Campylobacter jejuni. J Clin Microbiol 1987, 25:2274–2277.PubMed 60. Dorrell N, Mangan JA, Laing KG, Hinds J, Linton D, Al-Ghusein H, Barrell BG, Parkhill J, Stoker NG, Karlyshev AV, et al.: Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity. Genome Res 2001, 11:1706–1715.CrossRefPubMed 61.

Comments are closed.